Kozarich John W sold 500 shares of LIGAND PHARMACEUTICALS INC at $325.00 for −$163k on Nov 12, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Nov 16, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$162,500Shares × reported price
Shares traded
500Common Stock
Price per share
$325.00Reported price. Read footnotes for ranges.
% of reported position traded
1.17%This security and ownership context
Holdings after
42,122Direct
Trade date
Nov 12, 2026Sell
Filed
Nov 16, 2026, 4:24 PM ET4-day reporting delay
Accession
0001223000-26-000002Code S · Transaction 401843
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 42,622 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

LGND price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
LGND · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 23, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +0.6%1w ago −0.9%1d ago +5%
Returns since7d30d90d180d1y

Footnotes in full

F1: The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on August 12, 2026, in accordance with Rule 10b5-1.